Standard
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. / Rossignol, Patrick; Ménard, Joël; Fay, Renaud; Gustafsson, Finn; Pitt, Bertram; Zannad, Faiez.
I:
Journal of the American College of Cardiology, Bind 58, Nr. 19, 2011, s. 1958-66.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Rossignol, P, Ménard, J, Fay, R
, Gustafsson, F, Pitt, B & Zannad, F 2011, '
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy',
Journal of the American College of Cardiology, bind 58, nr. 19, s. 1958-66.
https://doi.org/10.1016/j.jacc.2011.04.049APA
Rossignol, P., Ménard, J., Fay, R.
, Gustafsson, F., Pitt, B., & Zannad, F. (2011).
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy.
Journal of the American College of Cardiology,
58(19), 1958-66.
https://doi.org/10.1016/j.jacc.2011.04.049Vancouver
Rossignol P, Ménard J, Fay R
, Gustafsson F, Pitt B, Zannad F.
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy.
Journal of the American College of Cardiology. 2011;58(19):1958-66.
https://doi.org/10.1016/j.jacc.2011.04.049Author
Rossignol, Patrick ; Ménard, Joël ; Fay, Renaud ; Gustafsson, Finn ; Pitt, Bertram ; Zannad, Faiez. / Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. I: Journal of the American College of Cardiology. 2011 ; Bind 58, Nr. 19. s. 1958-66.
Bibtex
@article{c6b3379b7fc44169a671836d4b7ea4ba,
title = "Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy",
abstract = "The purpose of this study was to determine whether a diuretic effect may be detectable in patients treated with eplerenone, a mineralocorticoid receptor antagonist, as compared with placebo during the first month of EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival study) (n = 6,080) and whether this was associated with eplerenone's beneficial effects on cardiovascular outcomes.",
author = "Patrick Rossignol and Jo{\"e}l M{\'e}nard and Renaud Fay and Finn Gustafsson and Bertram Pitt and Faiez Zannad",
note = "Copyright {\textcopyright} 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.",
year = "2011",
doi = "http://dx.doi.org/10.1016/j.jacc.2011.04.049",
language = "English",
volume = "58",
pages = "1958--66",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier",
number = "19",
}
RIS
TY - JOUR
T1 - Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy
AU - Rossignol, Patrick
AU - Ménard, Joël
AU - Fay, Renaud
AU - Gustafsson, Finn
AU - Pitt, Bertram
AU - Zannad, Faiez
N1 - Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
PY - 2011
Y1 - 2011
N2 - The purpose of this study was to determine whether a diuretic effect may be detectable in patients treated with eplerenone, a mineralocorticoid receptor antagonist, as compared with placebo during the first month of EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival study) (n = 6,080) and whether this was associated with eplerenone's beneficial effects on cardiovascular outcomes.
AB - The purpose of this study was to determine whether a diuretic effect may be detectable in patients treated with eplerenone, a mineralocorticoid receptor antagonist, as compared with placebo during the first month of EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival study) (n = 6,080) and whether this was associated with eplerenone's beneficial effects on cardiovascular outcomes.
U2 - http://dx.doi.org/10.1016/j.jacc.2011.04.049
DO - http://dx.doi.org/10.1016/j.jacc.2011.04.049
M3 - Journal article
VL - 58
SP - 1958
EP - 1966
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
SN - 0735-1097
IS - 19
ER -
